research Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
This study describes and characterizes four cases of alopecia areata induced by immune checkpoint inhibitor therapy in cancer patients, highlighting the importance of recognizing and managing these hair-related adverse events.

